The Role of Biologics and Other Systemic Agents in the Treatment of Pediatric PsoriasisMarch 1, 2010Psoriasis
The Treatment of Moderate-to-Severe Psoriasis: Prescreening and Monitoring Psoriatic Patients on BiologicsMarch 1, 2010Psoriasis
Anti-p40 Antibodies Ustekinumab and Briakinumab: Blockade of Interleukin-12 and Interleukin-23 in the Treatment of PsoriasisMarch 1, 2010Psoriasis
